Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 574, doi. 10.1007/s12272-021-01338-2
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2021 AND VI 44 AND IP 6
Results: 7
1
2
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 588, doi. 10.1007/s12272-021-01337-3
- By:
- Publication type:
- Article
3
Recent advances in CRISPR technologies for genome editing.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 537, doi. 10.1007/s12272-021-01336-4
- By:
- Publication type:
- Article
4
Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 621, doi. 10.1007/s12272-021-01335-5
- By:
- Publication type:
- Article
5
Inhibition of PI3K/mTOR/KATP channel blunts sodium thiosulphate preconditioning mediated cardioprotection against ischemia–reperfusion injury.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 605, doi. 10.1007/s12272-021-01339-1
- By:
- Publication type:
- Article
6
Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 564, doi. 10.1007/s12272-021-01334-6
- By:
- Publication type:
- Article
7
Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 6, p. 553, doi. 10.1007/s12272-021-01333-7
- By:
- Publication type:
- Article